Search research articles
Contact Us
Filters
Showing results (11-20 of 66) with videos related to
Page
of 7
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 31, 2007
First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?
Michael A Weber, Luis Ruilope, Thomas D Giles, et al.
Blood Pressure
|
August 9, 2019
Effect of angiotensin receptor blockers on blood pressure and renal function in patients with concomitant hypertension and chronic kidney disease: a systematic review and meta-analysis
Michel Burnier, Shanyan Lin, Luis Ruilope, et al.
Journal of Cardiovascular Pharmacology
|
April 25, 2006
Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials
Steve M Haffner, Luis Ruilope, Björn Dahlöf, et al.
International Journal of Cardiology
|
February 6, 2017
Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes
Juan Tamargo, Giuseppe M C Rosano, Eva Delpón, et al.
Journal of Hypertension
|
May 16, 2002
Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy
Alberto Zanchetti, Lennart Hansson, Gastone Leonetti, et al.
Lancet (London, England)
|
April 21, 2018
mHealth and the legacy of John Snow
Alejandro Santos-Lozano, Carlos Baladrón, Juan Martín-Hernández, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 2, 2010
Prevention of microalbuminuria in patients with type 2 diabetes: what do we know?
Luis Ruilope, Joseph Izzo, Hermann Haller, et al.
Blood Pressure
|
November 17, 2004
Effects of nifedipine GITS and diuretics in isolated systolic hypertension--a subanalysis of the INSIGHT study
Guiseppe Mancia, Luis Ruilope, Christopher Palmer, et al.
European Heart Journal
|
March 26, 2019
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
Felix Mahfoud, Michael Böhm, Roland Schmieder, et al.
BMC Nephrology
|
November 20, 2014
Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study
Luis Ruilope, Markolf Hanefeld, A Michael Lincoff, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 66) with videos related to
Sort By:
Page
of 7
Journal of Clinical Hypertension (Greenwich, Conn.)
|
March 31, 2007
First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?
Michael A Weber, Luis Ruilope, Thomas D Giles, et al.
Blood Pressure
|
August 9, 2019
Effect of angiotensin receptor blockers on blood pressure and renal function in patients with concomitant hypertension and chronic kidney disease: a systematic review and meta-analysis
Michel Burnier, Shanyan Lin, Luis Ruilope, et al.
Journal of Cardiovascular Pharmacology
|
April 25, 2006
Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials
Steve M Haffner, Luis Ruilope, Björn Dahlöf, et al.
International Journal of Cardiology
|
February 6, 2017
Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes
Juan Tamargo, Giuseppe M C Rosano, Eva Delpón, et al.
Journal of Hypertension
|
May 16, 2002
Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy
Alberto Zanchetti, Lennart Hansson, Gastone Leonetti, et al.
Lancet (London, England)
|
April 21, 2018
mHealth and the legacy of John Snow
Alejandro Santos-Lozano, Carlos Baladrón, Juan Martín-Hernández, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 2, 2010
Prevention of microalbuminuria in patients with type 2 diabetes: what do we know?
Luis Ruilope, Joseph Izzo, Hermann Haller, et al.
Blood Pressure
|
November 17, 2004
Effects of nifedipine GITS and diuretics in isolated systolic hypertension--a subanalysis of the INSIGHT study
Guiseppe Mancia, Luis Ruilope, Christopher Palmer, et al.
European Heart Journal
|
March 26, 2019
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
Felix Mahfoud, Michael Böhm, Roland Schmieder, et al.
BMC Nephrology
|
November 20, 2014
Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study
Luis Ruilope, Markolf Hanefeld, A Michael Lincoff, et al.
Page
of 7